Algorithms for a Single Hormone Closed-Loop Artificial Pancreas: Challenges Pertinent to Chemical Process Operations and Control

The development of a closed-loop artificial pancreas to regulate the blood glucose concentration of individuals with type 1 diabetes has been a focused area of research for over 50 years, with rapid progress during the past decade. The daily control challenges faced by someone with type 1 diabetes include asymmetric objectives and risks, and one-sided manipulated input action with frequent relatively fast disturbances. The major automation steps toward a closed-loop artificial pancreas include (i) monitoring and overnight alarms for hypoglycemia (low blood glucose); (ii) overnight low glucose suspend (LGS) systems to prevent hypoglycemia; and (iii) fully closed-loop systems that adjust insulin (and perhaps glucagon) to maintain desired blood glucose levels day and night. We focus on the steps that we used to develop and test a probabilistic, risk-based, model predictive control strategy for a fully closed-loop artificial pancreas. We complete the paper by discussing ramifications of lessons learned for chemical process systems applications.

[1]  Günter Niemeyer,et al.  A Closed-Loop Artificial Pancreas Based on Risk Management , 2011, Journal of diabetes science and technology.

[2]  B Wayne Bequette,et al.  Glucose Clamp Algorithms and Insulin Time-Action Profiles , 2009, Journal of diabetes science and technology.

[3]  Dale E. Seborg,et al.  Randomized Crossover Comparison of Personalized MPC and PID Control Algorithms for the Artificial Pancreas , 2016, Diabetes Care.

[4]  M. Feinleib.  National Center for Health Statistics (NCHS) , 2005 .

[5]  Ali Cinar,et al.  Adaptive control of artificial pancreas systems - a review. , 2014, Journal of healthcare engineering.

[6]  B. Wayne Bequette,et al.  Challenges and progress in the development of a closed-loop artificial pancreas , 2012, 2012 American Control Conference (ACC).

[7]  Darrell M. Wilson,et al.  A Randomized Trial of a Home System to Reduce Nocturnal Hypoglycemia in Type 1 Diabetes , 2014, Diabetes Care.

[8]  B. Wayne Bequette,et al.  Extended multiple model prediction with application to blood glucose regulation , 2012 .

[9]  B Wayne Bequette,et al.  A Novel Method to Detect Pressure-Induced Sensor Attenuations (PISA) in an Artificial Pancreas , 2014, Journal of diabetes science and technology.

[10]  Bruce Buckingham,et al.  Duration of Infusion Set Survival in Lipohypertrophy Versus Nonlipohypertrophied Tissue in Patients with Type 1 Diabetes. , 2016, Diabetes technology & therapeutics.

[11]  A BuckinghamBruce,et al.  Inpatient Trial of an Artificial Pancreas Based on Multiple Model Probabilistic Predictive Control with Repeated Large Unannounced Meals , 2014 .

[12]  H Peter Chase,et al.  Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy. , 2004, Pediatrics.

[13]  B. Wayne Bequette,et al.  Challenges and recent progress in the development of a closed-loop artificial pancreas , 2012, Annu. Rev. Control..

[14]  C. Cobelli,et al.  In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes , 2009, Journal of diabetes science and technology.

[15]  C H Best,et al.  Pancreatic Extracts in The Treatment of Diabetes Mellitus , 1956, Diabetes.

[16]  Lauren M. Huyett,et al.  Closed-Loop Artificial Pancreas Systems: Engineering the Algorithms , 2014, Diabetes Care.

[17]  G. Mcgarraugh.  The chemistry of commercial continuous glucose monitors. , 2009, Diabetes technology & therapeutics.

[18]  C. Cobelli,et al.  Artificial Pancreas: Past, Present, Future , 2011, Diabetes.

[19]  D. Cox,et al.  Symmetrization of the Blood Glucose Measurement Scale and Its Applications , 1997, Diabetes Care.

[20]  B Wayne Bequette,et al.  Algorithms for a Closed-Loop Artificial Pancreas: The Case for Model Predictive Control , 2013, Journal of diabetes science and technology.

[21]  W Kerner,et al.  Attempts at perfect normalization of glucose tolerance test of severe diabetics by artificial beta cell. , 1976, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[22]  S. Clarke,et al.  A history of blood glucose meters and their role in self-monitoring of diabetes mellitus , 2012, British journal of biomedical science.

[23]  Irl B Hirsch,et al.  Treatment of patients with severe insulin deficiency; what we have learned over the past 2 years. , 2004, The American journal of medicine.

[24]  Jay Stewart,et al.  The American Time Use Survey , 2005 .

[25]  M. Riddell,et al.  Exercise and Glucose Metabolism in Persons with Diabetes Mellitus: Perspectives on the Role for Continuous Glucose Monitoring , 2009, Journal of diabetes science and technology.

[26]  Eyal Dassau,et al.  Modular Artificial β-Cell System: A Prototype for Clinical Research , 2008 .

[27]  B Wayne Bequette,et al.  Fault Detection and Safety in Closed-Loop Artificial Pancreas Systems , 2014, Journal of diabetes science and technology.

[28]  B. Bequette.  A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas. , 2005, Diabetes technology & therapeutics.

[29]  R. Hovorka,et al.  Coming of age: the artificial pancreas for type 1 diabetes , 2016, Diabetologia.

[30]  J H Anderson,et al.  Graphical human insulin time-activity profiles using standardized definitions. , 2001, Diabetes technology & therapeutics.

[31]  Bruce Buckingham,et al.  Continuous Glucose Monitoring: Current Use and Future Directions , 2013, Current Diabetes Reports.

[32]  B. Wayne Bequette,et al.  Detecting sensor and insulin infusion set anomalies in an artificial pancreas , 2013, 2013 American Control Conference.

[33]  Howard C. Zisser,et al.  Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report , 2016, Diabetes Care.

[34]  G. Steil.  Algorithms for a Closed-Loop Artificial Pancreas: The Case for Proportional-Integral-Derivative Control , 2013, Journal of diabetes science and technology.

[35]  B. Wayne Bequette,et al.  Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis , 2015, Diabetes Care.

[36]  Eugeniusz Molga,et al.  Safety and Runaway Prevention in Batch and Semibatch Reactors—A Review , 2006 .

[37]  Ahmad Haidar,et al.  Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial. , 2015, The lancet. Diabetes & endocrinology.

[38]  Aesha Drozdowski,et al.  Standards of medical care in diabetes. , 2004, Diabetes care.

[39]  Günter Niemeyer,et al.  Inpatient trial of an artificial pancreas based on multiple model probabilistic predictive control with repeated large unannounced meals. , 2014, Diabetes technology & therapeutics.

[40]  Aaron J. Kowalski,et al.  Can we really close the loop and how soon? Accelerating the availability of an artificial pancreas: a roadmap to better diabetes outcomes. , 2009, Diabetes technology & therapeutics.

[41]  Antoine Robert,et al.  The Diabetes Assistant: A Smartphone-Based System for Real-Time Control of Blood Glucose , 2014 .

[42]  F. G. Shinskey,et al.  Process Control: As Taught vs as Practiced , 2002 .